Novavax, Inc. (NVAX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-06) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-26) · 99.1 | 8-K (2026-01-12) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-06) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-08) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-27) · 99.1 | 8-K (2025-01-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) | ||
| 10-Q | Q1-2024 | 8-K (2024-05-10) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-28) | 8-K (2024-01-08) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-09) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Comprehensive Income (loss) | ||
| Consolidated Balance Sheets | ||
| Consolidated Statements of Comprehensive Loss | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Changes In Stockholders' (deficit) | — |
|
| Consolidated Statements of Changes In Stockholders' Deficit | ||
| Consolidated Statements of Changes In Stockholders' Equity (deficit) | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Changes In Stockholders' Equity (deficit) (P) | ||
| Consolidated Statements of Changes In Stockholders' Deficit (P) | ||
| Notes | ||
| Cash, Cash Equivalents, and Restricted Cash | ||
| Collaboration, License, and Supply Agreements | ||
| Commitment and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Disposition of Assets | — |
|
| Earnings (loss) Per Share | — |
|
| Earnings Per Share | ||
| Employee Benefits | — |
|
| Fair Value Measurements | ||
| Goodwill | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Inventory | ||
| Leases | ||
| Long-term Debt | ||
| Marketable Securities | ||
| Organization & Business | — |
|
| Organization and Business | — |
|
| Other Financial Information | — |
|
| Pay Vs Performance Disclosure | ||
| Restructuring | ||
| Revenue | ||
| Segment Reporting | ||
| Stock-based Compensation | ||
| Stockholders Deficit | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||